CACNA2D1 monoclonal antibodies (Novassay)

N/A

Report date: 2025/06/11 10:48:13

Base Information

Drug NameCACNA2D1 monoclonal antibodies (Novassay)

Drug Alias NameCACNA2D1 monoclonal antibodies (Novassay)voltage-dependent calcium channel alpha-2 delta-1 subunit monoclonal antibodies (Novassay)NVA-1518NVA-1519NVA-1523 +[9]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionVoltage-gated calcium channel alpha2/delta subunit 1 blockers

TargetsVoltage-gated calcium channel alpha2/delta subunit 1

Therapy Area/IndicationsSolid tumoursNeuralgia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySwitzerland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovassay SA

China Registration ClassN/A

Develop Information

Active CompaniesNovassay SA

Inactive CompaniesN/A

Active IndicationsSolid tumoursNeuralgia

Inactive IndicationsN/A

Other Information

ATC CodeN/A